DUBLIN--(BUSINESS WIRE)--Covidien plc (NYSE: COV) today reported results for the third quarter of fiscal 2009 (April – June 2009). Third-quarter net sales declined 3% to $2.5 billion from $2.6 billion a year ago, with unfavorable foreign exchange of $143 million reducing the quarterly sales growth rate by approximately 5 percentage points. Operational growth, which excludes the impact of foreign exchange, was 2%, driven primarily by higher volume and new products.
